The Petri Dish: Selecta gets selective with drug programs; Moderna enters 2nd cancer vaccine collab

A Watertown biotech trimmed its pipeline again, setting aside all of its experimental drugs except one. It’s the second time the company has cut programs this year. Plus other life sciences news you may have missed.